Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults
Editorial Group: Cochrane Pain, Palliative and Supportive Care Group
Published Online: 18 APR 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Wong H, Tejani AM. Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD006844. DOI: 10.1002/14651858.CD006844.pub2.
- Publication Status: Amended to reflect a change in scope (see 'What's new')
- Published Online: 18 APR 2012
This is the protocol for a review and there is no abstract. The objectives are as follows:
- To assess the effect that NK-1 receptor antagonists have on the quality of life of patients treated with highly emetogenic chemotherapy.
- To assess the clinical efficacy of NK-1 receptor antagonists compared to standard antiemetic therapy in controlling emesis and nausea in participants on highly emetogenic chemotherapy.
- To determine the adverse events associated with NK-1 receptor antagonists in participants receiving these drugs.